Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Third party research

G5 Entertainment: Report on the weak side, and outlook cut - ABG

G5 Entertainment

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
Sales in line, but profitability and outlook worse

‘22e, ‘23e & ‘24e adj. EBIT cut by 7%, 7%, & 8%

New fair value range: SEK 230-390 per share (260-440)

Profitability hurt by FX, outlook for Sherlock impaired
G5 delivered Q2 sales of SEK 344m (+1% vs. ABGSCe, 0% vs. Infront cons.), for y-o-y growth of 2%, of which -13% organic. Sherlock was the primary growth driver, as expected, now comprising 20% of sales, up from 17% in Q1’22. Surprisingly, mgmt. decided not to extend the programme it initiated for Sherlock in May, to boost growth. We view this as negative but mgmt. reassured that the return profile still looks good for the game and that an investment programme for Sherlock could be reinitiated in the future. The main issue right now seems to be that mgmt. is worried about the trend of the overall market, more so than the KPIs for Sherlock, which is encouraging. Hidden City surprised positively, with flat sales q-o-q in USD, and slightly up in SEK terms. This, coupled with a higher share of Sherlock sales on iOS and Android, led to a lower gross margin of 66% vs. ABGSCe of 67%. Opex was higher than expected, SEK 226m vs. ABGSCe 215m, mainly due to higher FX. Because of this, EBIT was SEK 1m vs. ABGSCe SEK 15m and Infront consensus SEK 16m.

We cut the growth expectations for Sherlock
We make a couple of changes to estimates. We add the higher opex in Q2’22, and account for slightly higher opex in H2’22e as well, mainly due to FX and lower capitalisation. This effect is somewhat mitigated by lower UAC/sales in H2’22e. We leave 2022e sales relatively flat. For 2023e and 2024e we reduce our expectations for Sherlock following the announcement that UAC/sales will return to normal levels from August; we had previously expected the investment to have a thicker tail, fuelling more growth. Because of this, we cut ‘22e-‘24e adj. EBIT by 7%, 7%, and 8%.
We cut our fair value range to SEK 230-390 (260-440)
With lower expectations for Sherlock, we cut our fair value range to SEK 230...
Läs mer på ABG Sundal Collier
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team